We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells.
- Authors
Sun, Shuxin; Xue, Dongdong; Chen, Zhijie; Ou-yang, Ying; Zhang, Ji; Mai, Jialuo; Gu, Jiayv; Lu, Wanjun; Liu, Xincheng; Liu, Wenfeng; Sheng, Longxiang; Lu, Bingzheng; Lin, Yuan; Xing, Fan; Chen, Zhongping; Mou, Yonggao; Yan, Guangmei; Zhu, Wenbo; Sai, Ke
- Abstract
Given that glioma stem cells (GSCs) play a critical role in the initiation and chemoresistance in glioblastoma multiforme (GBM), targeting GSCs is an attractive strategy to treat GBM. Utilizing an anti-cancer compound library, we identified R406, the active metabolite of a FDA-approved Syk inhibitor for immune thrombocytopenia (ITP), with remarkable cytotoxicity against GSCs but not normal neural stem cells. R406 significantly inhibited neurosphere formation and triggered apoptosis in GSCs. R406 induced a metabolic shift from glycolysis to oxidative phosphorylation (OXPHOS) and subsequently production of excess ROS in GSCs. R406 also diminished tumor growth and efficiently sensitized gliomas to temozolomide in GSC-initiating xenograft mouse models. Mechanistically, the anti-GSC effect of R406 was due to the disruption of Syk/PI3K signaling in Syk-positive GSCs and PI3K/Akt pathway in Syk-negative GSCs respectively. Overall, these findings not only identify R406 as a promising GSC-targeting agent but also reveal the important role of Syk and PI3K pathways in the regulation of energy metabolism in GSCs.
- Publication
Cell Death & Disease, 2019, Vol 10, Issue 5, pN.PAG
- ISSN
2041-4889
- Publication type
Article
- DOI
10.1038/s41419-019-1587-0